Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations provided, so description carries full burden. It explains matching by name prefix, rolling up latest-year Part D claims, and including drug class flags with new-to-class signal. Pricing is disclosed. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Moderately sized, front-loaded with purpose. Each sentence adds value (inputs, outputs, data source, pricing). Could be slightly more concise but overall efficient.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Tool has 6 params and no output schema. Description explains inputs and output content (identity, summary, flags). Lacks exact return format, but is sufficiently complete for selection among sibling tools.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 67% (4 of 6 params described). Description adds meaning for 'name' (free-text, examples), 'state' (2-letter, comma-separated), 'specialty' (substring). 'limit' and 'offset' are common pagination; description could add more but still adds value beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it looks up a prescriber by name or NPI and returns identity plus a Medicare Part D prescribing summary. It lists specific outputs (top drug, distinct drugs, beneficiaries, class flags) and distinguishes from siblings by mentioning NPPES directory matching and Part D claims rollup.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides basic guidance: 'Provide name or npi' and optional state/specialty narrowing. Notes data source and pricing, but does not explicitly state when not to use this tool versus sibling tools like prescribers_partDByDrug_search or prescribers_partDClassWhitespace_search.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.